Vandortuzumab vedotin, CAS [[1471985-92-8]]

Produktübersicht

• Artikelname: Vandortuzumab vedotin, CAS [[1471985-92-8]]
• Artikelnummer: MCE-HY-P99528
• Hersteller Artikelnummer: HY-P99528
• Alternativnummer: MCE-HY-P99528-10MG, MCE-HY-P99528-5MG, MCE-HY-P99528-1MG, MCE-HY-P99528-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: DSTP 3086S, RG 7450, MSTP2109A

Produktbeschreibung

Vandortuzumab vedotin (DSTP 3086S, RG 7450) is a STEAP1-targeted antibody-drug conjugate (ADC). Vandortuzumab vedotin binds specifically to STEAP1, triggers internalization of the conjugate complex, mediates intracellular release of monomethyl auristatin E, inhibits cell division, and induces cell death. Vandortuzumab vedotin exhibits antitumor activity in preclinical prostate cancer xenografts. Vandortuzumab vedotin can be used for the research of metastatic castration-resistant prostate cancer[1].

Produkteigenschaften

• CAS Nummer: [1471985-92-8]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies